Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
Β 

Β 

STOCK EXCHANGE RELEASE

Β 

11 April 2017

Exova Group plc

Β 

Exova acquires SL Pharma Labs Incorporated

Β 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

Β 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBBGDSSGBBGRB
Date   Source Headline
10th Apr 201710:11 amRNSForm 8 (OPD)
7th Apr 20174:33 pmRNSForm 8 (OPD) Jacobs Holding AG (AMENDED)
7th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
7th Apr 20173:08 pmRNSForm 8.5 (EPT/RI) - Amendment - Exova Group Plc
7th Apr 201712:58 pmRNSForm 8.3 - Exova Group Plc
7th Apr 201710:32 amRNSForm 8 (OPD) Jacobs Holding AG
7th Apr 201710:29 amRNSForm 8.5 (EPT/RI)
6th Apr 20173:15 pmRNSForm 8.3 - Exova Group Plc
6th Apr 201711:20 amRNSForm 8.5 (EPT/RI) Exova Group Plc
6th Apr 201711:07 amRNSForm 8.3 - Exova Group PLC
6th Apr 201710:39 amRNSForm 8.5 (EPT/RI)
6th Apr 201710:25 amRNSForm 8.5 (EPT/RI)
6th Apr 20178:41 amRNSForm 8.3 - Exova Group PLC
5th Apr 20174:40 pmRNSForm 8.5 (EPT/RI) - Replacement
5th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
5th Apr 20171:16 pmRNSForm 8.3 - Exova Group PLC
5th Apr 201711:55 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
5th Apr 201711:26 amRNSForm 8.5 (EPT/RI)
5th Apr 20179:56 amRNSForm 8.5 (EPT/RI)
5th Apr 20177:13 amRNSForm 8.3 - Exova Group PLC
4th Apr 20171:15 pmRNSForm 8.3 - Exova Group PLC
4th Apr 201711:51 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
4th Apr 201711:17 amRNSForm 8.5 (EPT/RI)
4th Apr 201710:11 amRNSForm 8.5 (EPT/RI)
4th Apr 20177:09 amRNSForm 8.3 - Exova Group PLC
3rd Apr 20174:15 pmRNSForm 8 (OPD) Exova Group plc
3rd Apr 20171:59 pmRNSForm 8.3 - Exova Group PLC
3rd Apr 201712:15 pmRNSForm 8.5 (EPT/RI) - Exova Group Plc
3rd Apr 20179:37 amRNSForm 8.5 (EPT/RI)
31st Mar 20175:52 pmRNSForm 8.3 - Exova Group PLC
31st Mar 201712:33 pmRNSForm 8.3 - Exova Group plc
31st Mar 201711:37 amRNSForm 8.5 (EPT/RI) Exova Group Plc
31st Mar 201711:27 amRNSForm 8.5 (EPT/RI)
31st Mar 201711:03 amRNSForm 8.3 - Exova Group PLC
31st Mar 201711:01 amRNSForm 8.5 (EPT/RI)
31st Mar 201710:58 amRNSForm 8.3 - Exova Group PLC
31st Mar 201710:56 amRNSForm 8.3 - Exova Group PLC
31st Mar 201710:54 amRNSForm 8.3 - Exova Group PLC
30th Mar 201711:28 amRNSForm 8.5 (EPT/RI) Exova Group Plc
30th Mar 201711:12 amRNSForm 8.5 (EPT/RI)
30th Mar 201711:06 amRNSForm 8.5 (EPT/RI)
29th Mar 20175:21 pmRNSForm 8.5 (EPT/RI)-Amendment
29th Mar 20175:05 pmRNSTR-1: Notification of Major Interest in Shares
29th Mar 201711:38 amRNSForm 8.5 (EPT/RI) Exova Group Plc
29th Mar 201711:28 amRNSForm 8.5 (EPT/RI)
28th Mar 20173:20 pmRNSForm 8.3 - Exova Group Plc
28th Mar 20172:32 pmRNSForm 8.3 - [Exova Group Plc]
28th Mar 20171:35 pmRNSForm 8.3 - Exova Group PLC
28th Mar 20171:28 pmRNSForm 8.3 - Exova Group Plc
28th Mar 201712:00 pmRNSForm 8.3 - Exova Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.